Genetic Variants in METTL16 Affect the Risk of Non‐Syndromic Orofacial Clefts
Birth Defects Research · 2024
DOI: 10.1002/bdr2.2403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth Defects Research, 2024. Verfasst von Xinze Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Cleft Palate, Cleft Lip, Polymorphism, Single Nucleotide, Methyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Natural Science Foundation of the Jiangsu Higher Education Institutions of China.
Abstract (Originalsprache)
Objective
N6‐methyladenosine (m 6 A) is the most prevalent modification of RNA in eukaryotes which is associated with many cellular processes and diseases. Here, our objective is to explore whether genetic variants in m 6 A modification genes are associated with the risk of non‐syndrome orofacial clefts (NSOCs).
Methods
The transmission disequilibrium test (TDT) was performed to calculate the association between single nucleotide polymorphisms (SNPs) in m 6 A modification genes and NSOCs risk in 944 case‐parent trios. The function of SNP was predicted by HaploReg, RegulomeDB and histone enrichment data. The expression quantitative trait locus (eQTL) analysis was examined using Genotype‐Tissue Expression (GTEx) and eQTLGen. The role of gene in the development of NSOCs was assessed with correlation and enrichment analysis based on gene expression data in mice craniofacial tissue and zebrafish embryo.
Results
We identified that rs8078195 (A > C) in METTL16 was suggestively associated with the increased risk of NSOCs (OR = 1.32, p = 1.80E − 03). The region surrounding rs8078195 was subjected to deoxyribonuclease hypersensitivity and enriched with multiple histone modifications. In addition, it had a significant eQTL effect with METTL16 in skin tissue and human peripheral blood, which played an important role in NSOCs development. Bioinformatic analysis indicated that METTL16 contributed to the development of NSOCs probably by regulating cell cycle process.
Conclusions
Rs8078195 in METTL16 was associated with the occurrence of NSOCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing Medical University, Nanjing, China.
- Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing Medical University, Nanjing, China.
- Department of Orthodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Yongchu Pan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
- Chinese Postdoctoral Science Foundation
- Jiangsu Province Capability Improvement Project through Science, Technology and Education-Jiangsu Provincial Research Hospital Cultivation Unit
- Jiangsu Provincial Medical Innovation Center
Zitieren
APA
Xu, X., Li, X., Han, M., Xing, C., Zhu, G., Cui, X., Wang, L., Lou, S., & Pan, Y. (2024). Genetic Variants in METTL16 Affect the Risk of Non‐Syndromic Orofacial Clefts. Birth Defects Research. https://doi.org/10.1002/bdr2.2403
Vancouver
Xu X, Li X, Han M, Xing C, Zhu G, Cui X, et al. Genetic Variants in METTL16 Affect the Risk of Non‐Syndromic Orofacial Clefts. Birth Defects Research. 2024. doi:10.1002/bdr2.2403
BibTeX
@article{Xu2024,
author = {Xu, Xinze and Li, Xiaofeng and Han, Minxuan and Xing, Changyue and Zhu, Guirong and Cui, Xing and Wang, Lin and Lou, Shu and Pan, Yongchu},
title = {Genetic Variants in METTL16 Affect the Risk of Non‐Syndromic Orofacial Clefts},
journal = {Birth Defects Research},
year = {2024},
doi = {10.1002/bdr2.2403}
}
EUVIMED